Media
Here you’ll find relevant information about our company, including press, and events focusing on the development of tropical disease medicines for malaria prevention and dengue fever treatment.
Events
ON-DEMAND WEBINAR: Plans for Further Development of ARAKODA® (tafenoquine)
Please join CEO Geoffrey Dow as he discusses future plans for testing of ARAKODA® (tafenoquine) for potential use in COVID-19 in light of recent in vitro study results.
Press
December 15, 2021
Positive Phase II Study Data Suggest ARAKODA® (tafenoquine) Numerically Improved Clinical Recovery in Patients with Mild-Moderate COVID-19 Disease
November 19, 2021
ARAKODA® (tafenoquine) clinical safety, tolerability confirmed in long-term safety study; results published in Tropical Medicine and Infectious Disease
October 8, 2021
Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and Safety of ARAKODA® (tafenoquine) for Treatment of Mild-Moderate Covid-19 Disease
August 5, 2021
60 Degrees Pharmaceuticals Announces Completion of Long-Term Safety of ARAKODA® (tafenoquine) in Healthy Adult Volunteers
July 14, 2020
60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of ARAKODA® (tafenoquine) for COVID-19
November 21, 2019
Arakoda™ (tafenoquine) tablets, first prescription drug approved for malaria prevention by US FDA in over 18 years,
now available in US
March 20, 2019
60 Degrees Pharmaceuticals (60P) achieves first global product launch milestone
READ MORE
September 18, 2018
KODATEF® (tafenoquine) approved in Australia; first malaria prevention drug in more than two decades
READ MORE
August 27, 2018
Military scientists have discovered a new malaria drug that could help eradicate the disease — and it’s hitting shelves soon
READ MORE
August 9, 2018
U.S. Food and Drug Administration Approves ARAKODA™ (tafenoquine) tablets for oral use
READ MORE
July 26, 2018
U.S. FDA Advisory Committee votes in favor of Tafenoquine for the prevention of malaria
READ MORE
90,000,000+
Cases and 1 Million deaths in the U.S. from COVID-19 infections
627,000
Annual deaths from malaria globally
125,000,000
Travelers to endemic regions per annum
390,000,000
Dengue infections per year
202-327-5422
1025 Connecticut Ave. NW, Suite 1000, Washington, DC 20036